150 related articles for article (PubMed ID: 23299964)
1. Pleurodesis outcome in malignant pleural mesothelioma.
Fysh ET; Tan SK; Read CA; Lee F; McKenzie K; Olsen N; Weerasena I; Threlfall T; de Klerk N; Musk AW; Lee YC
Thorax; 2013 Jun; 68(6):594-6. PubMed ID: 23299964
[TBL] [Abstract][Full Text] [Related]
2. Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients.
Ak G; Metintaş M; Yildirim H; Metintaş S; Dündar E; Erginel S; Alataş F
Tuberk Toraks; 2009; 57(1):22-31. PubMed ID: 19533434
[TBL] [Abstract][Full Text] [Related]
3. Video-assisted cervical thoracoscopy: a novel approach for diagnosis, staging and pleurodesis of malignant pleural mesothelioma.
Chamberlain MH; Fareed K; Nakas A; Martin-Ucar AE; Waller DA
Eur J Cardiothorac Surg; 2008 Jul; 34(1):200-3. PubMed ID: 18450462
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in malignant pleural mesothelioma: role of talc pleurodesis.
Al-Alao BS; Parissis H; Rychlik IJ; Graham A; McGuigan J
Asian Cardiovasc Thorac Ann; 2012 Aug; 20(4):443-9. PubMed ID: 22879552
[TBL] [Abstract][Full Text] [Related]
5. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial.
Rintoul RC; Ritchie AJ; Edwards JG; Waller DA; Coonar AS; Bennett M; Lovato E; Hughes V; Fox-Rushby JA; Sharples LD;
Lancet; 2014 Sep; 384(9948):1118-27. PubMed ID: 24942631
[TBL] [Abstract][Full Text] [Related]
7. [Value of thoracoscopy and talc pleurodesis in diagnosis and palliative treatment of malignant pleural mesothelioma].
Charvat JC; Brutsche M; Frey JG; Tschopp JM
Praxis (Bern 1994); 1998 Mar; 87(10):336-40. PubMed ID: 9545840
[TBL] [Abstract][Full Text] [Related]
8. Can serum inflammatory parameters estimate outcome of pleurodesis in mesothelioma?
Bilgin M; Hasdiraz L; Ozkaya M; Oguzkaya F
ANZ J Surg; 2007 Apr; 77(4):253-5. PubMed ID: 17388830
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series.
Aelony Y; Yao JF
Respirology; 2005 Nov; 10(5):649-55. PubMed ID: 16268920
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
Kolschmann S; Ballin A; Gillissen A
Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
[TBL] [Abstract][Full Text] [Related]
11. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma.
Rena O; Boldorini R; Papalia E; Mezzapelle R; Baietto G; Roncon A; Casadio C
Ann Thorac Surg; 2015 Apr; 99(4):1177-83. PubMed ID: 25669666
[TBL] [Abstract][Full Text] [Related]
12. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
13. Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results.
Basso SM; Mazza F; Marzano B; Santeufemia DA; Chiara GB; Lumachi F
Anticancer Res; 2012 Nov; 32(11):5131-4. PubMed ID: 23155293
[TBL] [Abstract][Full Text] [Related]
14. Video-assisted thoracoscopic pleurodesis for malignant pleural effusions.
Füredi A; Kecskés L; Gehér P; Kiss B
Acta Chir Hung; 1999; 38(2):155-7. PubMed ID: 10596319
[TBL] [Abstract][Full Text] [Related]
15. The pathology associated with therapeutic procedures in malignant mesothelioma.
Attanoos RL; Gibbs AR
Histopathology; 2004 Oct; 45(4):393-7. PubMed ID: 15469478
[TBL] [Abstract][Full Text] [Related]
16. Videothoracoscopy in the diagnosis and treatment of malignant pleural mesothelioma with associated pleural effusions.
Cantó A; Guijarro R; Arnau A; Galbis J; Martorell M; García Aguado R
Thorac Cardiovasc Surg; 1997 Feb; 45(1):16-9. PubMed ID: 9089969
[TBL] [Abstract][Full Text] [Related]
17. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial.
Mohsen TA; Zeid AA; Meshref M; Tawfeek N; Redmond K; Ananiadou OG; Haj-Yahia S
Eur J Cardiothorac Surg; 2011 Aug; 40(2):282-6. PubMed ID: 20961772
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of pleural fluid pH in malignant epithelial mesothelioma after talc poudrage.
Aelony Y; Yao JF; King RR
Respiration; 2006; 73(3):334-9. PubMed ID: 16679752
[TBL] [Abstract][Full Text] [Related]
19. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.
Aydogmus U; Ozdemir S; Cansever L; Sonmezoglu Y; Kocaturk CI; Bedirhan MA
Ann Surg Oncol; 2009 Mar; 16(3):745-50. PubMed ID: 19116753
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of malignant pleural effusion by pleurodesis with talc].
Filippetti M; Crucitti G; Vanni B; Della Giulia M; Foggi P; Del Monte G
Chir Ital; 2000; 52(5):541-7. PubMed ID: 11190547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
